Paloma Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-30,900
Closed -$3.21M 430
2024
Q3
$3.21M Buy
30,900
+7,200
+30% +$734K 0.09% 199
2024
Q2
$2.3M Buy
+23,700
New +$2.19M 0.06% 319
2024
Q1
Sell
-18,900
Closed -$1.51M 812
2023
Q4
$1.51M Buy
18,900
+5,500
+41% +$414K 0.06% 329
2023
Q3
$953K Buy
+13,400
New +$1M 0.03% 380
2021
Q3
Sell
-51,000
Closed -$4.15M 1193
2021
Q2
$4.15M Buy
+51,000
New +$4.17M 0.07% 239
2019
Q3
Sell
-8,200
Closed -$588K 1995
2019
Q2
$588K Buy
+8,200
New +$582K 0.01% 957
2018
Q4
Sell
-62,000
Closed -$4.15M 1331
2018
Q3
$4.15M Buy
+62,000
New +$4.13M 0.08% 223

Other funds holding CL

Paloma Partners's CL Position: Q4 2024 in Review

Paloma Partners sold out of Colgate-Palmolive (CL) in Q4 2024, closing a stake of 29,915 shares — an estimated $3.11M sold.

Paloma Partners first reported a position in CL in Q2 2013 and held it in 34 quarters. The position peaked at $24.4M in Q2 2021. 1,933 funds tracked by Wall St. Rank hold CL as of Q4 2024.

  • Paloma Partners reported no remaining Colgate-Palmolive position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 29,915 Colgate-Palmolive shares in Q4 2024, an estimated $3.11M.
  • Paloma Partners first reported a position in Colgate-Palmolive in Q2 2013 and held it in 34 quarters.
  • Paloma Partners's Colgate-Palmolive position peaked at $24.4M in Q2 2021.
  • 1,933 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.